sign in sign up
<<
Home , Hydromorphinol

Federal Register / Vol. 77, No. 228 / Tuesday, November 27, 2012 / Notices 70825

Dated: November 19, 2012. Dated: November 19, 2012. quintuplicate, to the Drug Enforcement Joseph T. Rannazzisi, Joseph T. Rannazzisi, Administration, Office of Diversion Deputy Assistant Administrator, Office of Deputy Assistant Administrator, Office of Control, Federal Register Representative Diversion Control, Drug Enforcement Diversion Control, Drug Enforcement (ODL), 8701 Morrissette Drive, Administration. Administration. Springfield, Virginia 22152; and must be [FR Doc. 2012–28667 Filed 11–26–12; 8:45 am] [FR Doc. 2012–28664 Filed 11–26–12; 8:45 am] filed no later than January 28, 2013. BILLING CODE 4410–09–P BILLING CODE 4410–09–P Dated: November 19, 2012. Joseph T. Rannazzisi, DEPARTMENT OF JUSTICE Deputy Assistant Administrator, Office of DEPARTMENT OF JUSTICE Diversion Control, Drug Enforcement Drug Enforcement Administration Administration. Drug Enforcement Administration [FR Doc. 2012–28662 Filed 11–26–12; 8:45 am] Manufacturer of Controlled BILLING CODE 4410–09–P Manufacturer of Controlled Substances; Notice of Application; Substances; Notice of Application; Norac Siegfried (USA), LLC DEPARTMENT OF LABOR Pursuant to § 1301.33(a), Title 21 of Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), Office of the Secretary the Code of Federal Regulations (CFR), this is notice that on October 31, 2012, this is notice that on November 5, 2012, Norac, DBA: Norac Pharma, 405 S. Agency Information Collection Siegfried (USA) LLC, 33 Industrial Park Motor Avenue, Azusa, California Activities; Submission for OMB Road, Pennsville, New Jersey 08070, 91702–3232, made application by Review; Comment Request; DOL made application by renewal to the renewal to the Drug Enforcement Generic Solution for Customer Drug Enforcement Administration Administration (DEA) to be registered as Satisfaction Surveys and Conference (DEA) to be registered as a bulk a bulk manufacturer of the following Evaluations manufacturer of the following basic basic classes of controlled substances: ACTION: Notice. classes of controlled substances: Drug Schedule SUMMARY: The Department of Labor Drug Schedule Gamma Hydroxybutyric Acid I (DOL) is submitting the information (2010). collection request (ICR) titled, ‘‘DOL Gamma Hydroxybutyric Acid I (7370) ..... I Generic Solution for Customer (2010). Methamphetamine (1105) ...... II Satisfaction Surveys and Conference (9145) ...... I Pentobarbital (2270) ...... II Evaluations,’’ to the Office of Hydromorphinol (9301) ...... I Nabilone (7379) ...... II Management and Budget (OMB) for Methylphenidate (1724) ...... II Amobarbital (2125) ...... II review and approval for continued use With regard to gamma hydroxybutyric in accordance with the Paperwork Pentobarbital (2270) ...... II acid (2010), tetrahydrocannabinols Secobarbital (2315) ...... II Reduction Act (PRA) of 1995 (44 U.S.C. (7370), and methamphetamine (1105) 3501 et seq.). (9050) ...... II only, the company manufactures these DATES: (9143) ...... II controlled substances in bulk solely for Submit comments on or before (9150) ...... II domestic distribution within the United December 27, 2012. (9193) ...... II States to customers engaged in dosage- ADDRESSES: A copy of this ICR with (9250) ...... II form manufacturing. applicable supporting documentation; Methadone intermediate (9254) ... II With regard to Nabilone (7379), the including a description of the likely , bulk (non- II company presently manufactures a respondents, proposed frequency of dosage forms) (9273). small amount of this controlled response, and estimated total burden (9300) ...... II substance in bulk solely to conduct may be obtained from the RegInfo.gov (9330) ...... II manufacturing process development Web site, http://www.reginfo.gov/ (9652) ...... II internally within the company. It is the public/do/PRAMain, on the day company’s intention that, when the following publication of this notice or The company plans to manufacture manufacturing process is refined to the by contacting Michel Smyth by the listed controlled substances in bulk point that its Nabilone bulk product is telephone at 202–693–4129 (this is not for distribution to its customers. available for commercial use, the a toll-free number) or sending an email to [email protected]. Any other such applicant, and any company will export the controlled Submit comments about this request person who is presently registered with substance in bulk solely to customers engaged in dosage-form manufacturing to the Office of Information and DEA to manufacture such substances, Regulatory Affairs, Attn: OMB Desk may file comments or objections to the outside the United States. The company is aware of the requirement to obtain a Officer for DOL-Departmental issuance of the proposed registration Management, Office of Management and pursuant to 21 CFR § 1301.33(a). DEA registration as an exporter to conduct this activity. Budget, Room 10235, 725 17th Street, Any such written comments or Any other such applicant, and any NW., Washington, DC 20503, Fax: 202– objections should be addressed, in person who is presently registered with 395–6881 (this is not a toll-free quintuplicate, to the Drug Enforcement DEA to manufacture such substances, number), email: _ Administration, Office of Diversion may file comments or objections to the OIRA [email protected]. Control, Federal Register Representative issuance of the proposed registration FOR FURTHER INFORMATION CONTACT: (ODL), 8701 Morrissette Drive, pursuant to 21 CFR 1301.33(a). Michel Smyth by telephone at 202–693– Springfield, Virginia 22152; and must be Any such written comments or 4129 (this is not a toll-free number) or filed no later than January 28, 2013. objections should be addressed, in by email at [email protected].

VerDate Mar<15>2010 15:05 Nov 26, 2012 Jkt 229001 PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1 wreier-aviles on DSK5TPTVN1PROD with